Advanced Lipolytic Formula : Accelerates fat dissolution and metabolism
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, has shown even more impressive weight loss data than tirzepatide in early trials
However, Lillys tirzepatide has some edges (e.g., trial efficacy and investor perception of pipeline strength) that have allowed Lilly to close the gap
These include: Lower calorie intake: Tirzepatide can significantly reduce appetite and, in turn, calorie intake
D., Pal, S., Yang, L., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K
If you have specific health concerns or medical conditions, please consult with a licensed healthcare provider prior to receiving any IV infusion